Melanotan II is a melanocortin agonist (MC1R/MC3R/MC4R). It is filed in this library under skin & aging, a navigation topic rather than a statement of where it acts. As a regulatory matter it is not approved by the FDA for any use.
Regulatory status
Melanotan II is not approved by the FDA for any use.
It is sold outside the approved-drug system, which means no regulator has reviewed its manufacturing, its purity or its effects.
The evidence
4 sources on Melanotan II published between 1996 and 2014, each resolved to its journal of record. Titles are listed so you can judge the evidence rather than take a summary on trust.
Nearby
Before any compound, the useful question is what your bloodwork already says. The OPTML Score reads a full panel against optimal ranges.
See the OPTML ScoreEducational reference only. This page explains what has been published about Melanotan II. It is not medical advice, it is not a diagnosis, and it carries no dosing information of any kind. OPTML does not offer or supply this compound unless a product page on this site says otherwise.
Treatment decisions are made by a licensed physician after an individual evaluation. Compounded preparations are not FDA-approved or evaluated by the FDA for safety, effectiveness, or quality. Individual results vary.
All 150 peptides